A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma

Pigment Cell&Melanoma Research,Volume 31, Issue 4, Page 534-540, July 2018.

Source: Pigment Cell Research - April 10, 2018 Category: Cytology Authors: Janice M. Mehnert , Ann W. Silk , J. H. Lee , Liesel Dudek , Byeong ‐Seon Jeong , Jiadong Li , Jason M. Schenkel , Evita Sadimin , Michael Kane , Hongxia Lin , Weichung J. Shih , Andrew Zloza , Suzie Chen Source Type: research